Ikena Oncology Statistics Share Statistics Ikena Oncology has 41.89M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 41.89M Shares Change (YoY) 0% Shares Change (QoQ) -0.02% Owned by Institutions (%) 67.86% Shares Floating 6.11M Failed to Deliver (FTD) Shares 1 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 168.63K, so 0.35% of the outstanding
shares have been sold short.
Short Interest 168.63K Short % of Shares Out 0.35% Short % of Float 0.39% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -19.29 and the forward
PE ratio is -22.88.
Ikena Oncology's PEG ratio is
0.52.
PE Ratio -19.29 Forward PE -22.88 PS Ratio 0 Forward PS 205.4 PB Ratio 7.54 P/FCF Ratio -20.64 PEG Ratio 0.52
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Ikena Oncology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 11.8,
with a Debt / Equity ratio of 0.06.
Current Ratio 11.8 Quick Ratio 11.8 Debt / Equity 0.06 Debt / EBITDA -0.15 Debt / FCF -0.16 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-4.92M Employee Count 10 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 152K Effective Tax Rate -0.31%
Stock Price Statistics The stock price has increased by -12.8% in the
last 52 weeks. The beta is 0.5, so Ikena Oncology's
price volatility has been higher than the market average.
Beta 0.5 52-Week Price Change -12.8% 50-Day Moving Average 15.62 200-Day Moving Average 17.24 Relative Strength Index (RSI) 59.82 Average Volume (20 Days) 18,002
Income Statement
Revenue n/a Gross Profit n/a Operating Income -58.97M Net Income -49.23M EBITDA -48.59M EBIT -49.08M Earnings Per Share (EPS) -1.02
Full Income Statement Balance Sheet The company has 39.39M in cash and 7.52M in
debt, giving a net cash position of 31.87M.
Cash & Cash Equivalents 39.39M Total Debt 7.52M Net Cash 31.87M Retained Earnings -331.62M Total Assets 126.17M Working Capital 91.69M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -46M
and capital expenditures 0, giving a free cash flow of -46M.
Operating Cash Flow -46M Capital Expenditures n/a Free Cash Flow -46M FCF Per Share -0.95
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields IKNA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for IKNA is $162,
which is 844.1% higher than the current price. The consensus rating is "Hold".
Price Target $162 Price Target Difference 844.1% Analyst Consensus Hold Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 28, 2025. It was a
backward
split with a ratio of 1:12.
Last Split Date Jul 28, 2025 Split Type backward Split Ratio 1:12
Scores Altman Z-Score 38.01 Piotroski F-Score 2
